Medications for Obstructive Sleep Apnea

8 results
Mylan Pharmaceuticals Inc.
Usage: Armodafinil tablets are indicated for improving wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. It treats excessive sleepiness in OSA but is not a treatment for the underlying condition. CPAP therapy should be prioritized before starting armodafinil.
DIRECT RX
Usage: Armodafinil tablets are indicated for improving wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. Notably, it treats sleepiness but does not address the underlying causes of OSA. CPAP treatment should be prioritized for OSA patients before starting armodafinil.
Teva Pharmaceuticals USA, Inc.
Usage: Armodafinil tablets are indicated for improving wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. It is not a treatment for the underlying cause of OSA and should be used after attempting CPAP therapy.
Sandoz Inc
Usage: Armodafinil tablets are indicated to improve wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. They are not a treatment for the underlying causes of obstructive sleep apnea and should be used after attempts to use CPAP have been made.
Preferred Pharmaceuticals Inc.
Usage: Armodafinil tablets are indicated to improve wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. It is important to note that in obstructive sleep apnea, it does not treat the underlying condition.
Aurobindo Pharma Limited
Usage: Armodafinil tablets are indicated for improving wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. It is not a treatment for the underlying causes of OSA and should be used only after considering CPAP therapy.

Sunosi (solriamfetol)

(solriamfetol)
Axsome Therapeutics, Inc.
Usage: SUNOSI is indicated for improving wakefulness in adults with excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea (OSA). It is not a treatment for the underlying airway obstruction in OSA and should be used alongside appropriate therapies like CPAP.
Eli Lilly and Company
Usage: ZEPBOUND® is indicated for weight reduction and long-term maintenance in adults with obesity or overweight and at least one related comorbid condition, as well as for treating moderate to severe obstructive sleep apnea in adults with obesity, in conjunction with a reduced-calorie diet and physical activity.